Stay updated with breaking news from Maxcyte daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
MaxCyte, Inc. (NASDAQ:MXCT – Get Free Report)’s stock price traded up 10.3% on Wednesday . The stock traded as high as $5.21 and last traded at $5.16. 556,810 shares changed hands during trading, a decline of 6% from the average session volume of 592,066 shares. The stock had previously closed at $4.68. Analyst Ratings Changes […] ....
MaxCyte, Inc. (NASDAQ:MXCT – Get Free Report) CEO Maher Masoud acquired 70,443 shares of the stock in a transaction dated Monday, June 10th. The stock was bought at an average cost of $4.90 per share, with a total value of $345,170.70. Following the completion of the purchase, the chief executive officer now owns 100,000 shares […] ....
Cadian Capital Management LP bought a new position in shares of MaxCyte, Inc. (NASDAQ:MXCT – Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 5,644,898 shares of the company’s stock, valued at approximately $26,531,000. MaxCyte comprises 1.1% of Cadian Capital […] ....
Cadian Capital Management LP acquired a new position in MaxCyte, Inc. (NASDAQ:MXCT – Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 5,644,898 shares of the company’s stock, valued at approximately $26,531,000. MaxCyte comprises about 1.1% of Cadian […] ....
Equities Analysts Set Expectations for MaxCyte, Inc.'s Q1 2025 Earnings (NASDAQ:MXCT) dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.